Fenoterol but not dobutamine increases erythropoietin production in humans
- 19 June 1997
- journal article
- clinical trial
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 61 (6) , 669-676
Abstract
This study assessed the role of adrenergic signal transmission in the control of renal erythropoietin (EPO) production in humans. Forty-six healthy male volunteers underwent a hemorrhage of 750 ml. After phlebotomy, they received (intravenously for 6 hours in a parallel, randomized, placebo-controlled and single-blind design) either placebo (0.9% sodium chloride), or the beta 2-adrenergic receptor agonist fenoterol (1.5 microgram/min), or the beta 1-adrenergic receptor agonist dobutamine (5 micrograms/kg/min), or the nonselective beta-adrenergic receptor antagonist propranolol (loading dose of 0.14 mg/kg over 20 minutes, followed by 0.63 micrograms/kg/min). The AUCEPO(0-48 hr)fenoterol was 37% higher (p < 0.03) than AUCEPO(0-48 hr)placebo, whereas AUCEPO(0-48 hr)dobutamine and AUCEPO(0-48 hr)propranolol were comparable with placebo. Creatinine clearance was significantly increased during dobutamine treatment. Urinary cyclic adenosine monophosphate excretion was increased only by fenoterol treatment, whereas serum potassium levels were decreased. Plasma renin activity was significantly increased during dobutamine and fenoterol infusion. This study shows in a model of controlled, physiologic stimulation of renal erythropoietin production that the beta 2-adrenergic receptor agonist fenoterol but not the beta 1-adrenergic receptor agonist dobutamine is able to increase erythropoietin levels in humans. The result can be interpreted as a hint that signals for the control of erythropoietin production may be mediated by beta 2-adrenergic receptors rather than by beta 1-adrenergic receptors. It appears to be unlikely that an increase of renin concentrations or glomerular filtration rate is causally linked to the control of erythropoietin production in this experimental setting.Keywords
This publication has 17 references indexed in Scilit:
- Erythropoietin production in healthy volunteers subjected to controlled haemorrhage: evidence against a major role for adenosineBritish Journal of Clinical Pharmacology, 1996
- Angiotensin Receptors and Their AntagonistsNew England Journal of Medicine, 1996
- Erythropoietin (EPO) Levels in Fetal Rats after Ritodrine and Terbutaline AdministrationBiochemical Medicine and Metabolic Biology, 1994
- Erythropoietin: Oxygen-Dependent Control of Erythropoiesis and Its Failure in Renal DiseaseNephron, 1994
- Erythropoietin Production by Fetal Mouse Liver Cells in Response to Hypoxia and Adenylate Cyclase Stimulation*Endocrinology, 1986
- Hypokalemia from Beta2-Receptor Stimulation by Circulating EpinephrineNew England Journal of Medicine, 1983
- Effects of Adrenergic Activators and Inhibitors on Kidney Function1981
- β2‐ADRENOCEPTORS MEDIATE THE STIMULATING EFFECT OF ADRENALINE ON ACTIVE ELECTROGENIC NA‐K‐TRANSPORT IN RAT SOLEUS MUSCLEBritish Journal of Pharmacology, 1980
- Nephrogenous Cyclic Adenosine Monophosphate as a Parathyroid Function TestJournal of Clinical Investigation, 1977
- Plasma Propranolol Levels in the Quantitative Assessment of β-adrenergic Blockade in ManBMJ, 1970